REDISTRA Imatinib Mesylate Capsules 100 mg

מדינה: מלזיה

שפה: אנגלית

מקור: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

מרכיב פעיל:

IMATINIB MESYLATE

זמין מ:

Dr. Reddy`s Laboratories Malaysia Sdn. Bhd.

INN (שם בינלאומי):

IMATINIB MESYLATE

יחידות באריזה:

60capsule Capsules; 60capsule Capsules

תוצרת:

Dr Reddy`s Laboratories Ltd

עלון מידע

REDISTRA
Imatinib Mesylate Capsules 100mg
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
WHAT IS IN THIS LEAFLET
1. What REDISTRA is used for
2. How REDISTRA works
3. Before you use REDISTRA
4. How to use REDISTRA
5. While you are using it
6. Side effects
7. Storage and Disposal of
REDISTRA
_ _
_8. _
Product Description
9. Manufacturer and Product
Registration Holder
10. Date of revision
1.WHAT
REDISTRA
_ _IS USED FOR
Imatinib works by inhibiting the
growth of abnormal cells in the
diseases
listed
below.
These
include some types of cancer.
IMATINIB
IS
A
TREATMENT
FOR
ADULTS AND CHILDREN FOR:

CHRONIC
MYELOID
LEUKAEMIA
(CML).
Leukaemia
is
a
cancer
of
white
blood
cells.
These
white cells usually help the
body
to
fight
infection.
Chronic myeloid leukaemia
is a form of leukaemia in
which
certain
abnormal
white cells (named myeloid
cells) start growing out of
control.

PHILADELPHIA CHROMOSOME
POSITIVE
ACUTE
LYMPHOBLASTIC
LEUKAEMIA
(PH-POSITIVE ALL)
.
Leukaemia
is
a
cancer
of
white
blood
cells.
These
white cells usually help the
body
to
fight
infection.
Acute
lymphoblastic
leukaemia
is
a
form
of
leukaemia in which certain
abnormal white cells (named
lymphoblasts) start growing
out
of
control.
Imatinib
inhibits the growth of these
cells.
IMATINIB IS ALSO A TREATMENT FOR
ADULTS FOR:

MYELODYSPLASTIC/MYEL
OPROLIFERATIVE DISEASES
(MDS/MPD).
These
are
a
group
of
blood
diseases in which some
blood
cells
start
growing out of control.
Imatinib
inhibits
the
growth of these cells in
a
certain
subtype
of
these diseases.

HYPEREOSINOPHILIC
SYNDROME
(HES)
AND/OR
CHRONIC
EOSINOPHILIC
LEUKAEMIA
(CEL).
These
are
blood
diseases in which some
blood
cells
(named
eosinophils)
start
growing out of control.
Imatinib
inhibits
the
growth of these cells in
a
certain
subtype
of
these diseases.
 GASTROINTESTINAL
STROMAL
TUMOURS
(GIST).
GIST
is
a
cancer of the stomach
and
bowels.
It
arises
from
uncontrolled
cell
growth
of
the
supporting
tissues
of
these organs.

DERMATOFIBROSARCOMA
PROTUBERANS
(DFSP).
DFSP is a cancer of the